VA
Valneva SE
VALN · NASDAQ
$6.56 +0.15% (+$0.01)
1M -2.81%
Market Cap 541.7M €
P/E Ratio -
Div. Yield -
ROE 152.63%
Piotroski F-Score Weak
1/9Valuation
32 /100
Expensive P/B 6.68x
P/S 3.77x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 21.54%
Rev. growth 21.52%
FCF growth N/A
Profitability
4 /100
Weak Op. margin 80.93%
Gross margin 16.35%
FCF margin 59.70%
Quality
5 /100
Poor ROA 40.75%
ROIC 37.97%
Asset turnover 0.37x
Debt
23 /100
High Int. coverage -2.83x
Debt/Equity 2.59x
Current ratio 2.16x
Stability
16 /100
Unstable EPS volatility 428.59%
Beta 1.35x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre VALN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
674
Headquarters
Saint-Herblain
Evenimente viitoare
19 NOV.
Earnings
Upcoming earnings report